These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36930854)

  • 1. Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.
    Eriksson M; Czene K; Vachon C; Conant EF; Hall P
    J Clin Oncol; 2023 May; 41(14):2536-2545. PubMed ID: 36930854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer.
    Eriksson M; Czene K; Vachon C; Conant EF; Hall P
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
    Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening-a nested case-control study.
    Eriksson M; Román M; Gräwingholt A; Castells X; Nitrosi A; Pattacini P; Heywang-Köbrunner S; Rossi PG
    Lancet Reg Health Eur; 2024 Feb; 37():100798. PubMed ID: 38362558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
    van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
    Yala A; Lehman C; Schuster T; Portnoi T; Barzilay R
    Radiology; 2019 Jul; 292(1):60-66. PubMed ID: 31063083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
    Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
    Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Breast Cancer Risk by Combining AI for Lesion Detection and Mammographic Texture.
    Lauritzen AD; von Euler-Chelpin MC; Lynge E; Vejborg I; Nielsen M; Karssemeijer N; Lillholm M
    Radiology; 2023 Aug; 308(2):e230227. PubMed ID: 37642571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of breast cancer risk for sisters of women attending screening.
    Mao X; He W; Eriksson M; Lindström LS; Holowko N; Bajalica-Lagercrantz S; Hammarström M; Grassmann F; Humphreys K; Easton D; Hall P; Czene K
    J Natl Cancer Inst; 2023 Nov; 115(11):1310-1317. PubMed ID: 37243694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.